Advertisement
Research Article

Identification of Replication Competent Murine Gammaretroviruses in Commonly Used Prostate Cancer Cell Lines

  • Karen Sandell Sfanos mail,

    ksfanos@jhmi.edu

    Affiliation: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    X
  • Amanda L. Aloia,

    Affiliation: HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

    X
  • Jessica L. Hicks,

    Affiliation: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    X
  • David M. Esopi,

    Affiliation: Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States of America

    X
  • Jared P. Steranka,

    Affiliation: Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    X
  • Wei Shao,

    Affiliation: Advanced Biomedical Computing Center, Science Applications International Corporation, Frederick, Maryland, United States of America

    X
  • Silvia Sanchez-Martinez,

    Affiliation: HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

    X
  • Srinivasan Yegnasubramanian,

    Affiliation: Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States of America

    X
  • Kathleen H. Burns,

    Affiliations: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    X
  • Alan Rein,

    Affiliation: HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

    X
  • Angelo M. De Marzo

    Affiliations: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States of America, Department of Urology, The Brady Urological Research Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    X
  • Published: June 17, 2011
  • DOI: 10.1371/journal.pone.0020874

About the Authors

Karen Sandell Sfanos, Jessica L. Hicks, Kathleen H. Burns, Angelo M. De Marzo
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
Amanda L. Aloia, Silvia Sanchez-Martinez, Alan Rein
HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America
David M. Esopi, Srinivasan Yegnasubramanian, Angelo M. De Marzo
Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States of America
Jared P. Steranka, Kathleen H. Burns
Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
Wei Shao
Advanced Biomedical Computing Center, Science Applications International Corporation, Frederick, Maryland, United States of America
Angelo M. De Marzo
Department of Urology, The Brady Urological Research Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

Corresponding Author

Email: ksfanos@jhmi.edu

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: KSS ALA JPS KHB AR AMDM. Performed the experiments: KSS ALA JLH DME JPS SS-M. Analyzed the data: KSS ALA JPS WS SY KHB AR AMDM. Contributed reagents/materials/analysis tools: ALA DME JPS WS SY KHB AR. Wrote the paper: KSS ALA AR AMDM.